GHK-Cu copper peptides: separating skin science from TikTok hype

What did @dermdebunks actually say?

Allison, a PA in dermatology, made two distinct arguments: injectable GHK-Cu is illegal and potentially dangerous, while topical GHK-Cu has real biological merit for skin hydration, fine lines, and pigmentation. She was measured, not breathless about it. She called peptides "exciting" while telling viewers they won't replace a solid skincare routine. That's a more honest framing than most of what circulates under the #peptide hashtag.

She specifically flagged compounding pharmacy risks, the absence of human data on injectable GHK-Cu, and the theoretical problem of protein aggregation at higher injected doses. These are not throwaway caveats. They're the right questions to be asking about an unregulated injectable.

Does the science back this up?

On topical GHK-Cu, she's on solid ground. The evidence is real, if not overwhelming. Pickart and Margolina (2018, Cosmetics) summarized decades of work showing GHK-Cu stimulates collagen synthesis, promotes wound healing, and modulates skin remodeling via TGF-beta pathways. A double-blind study by Leyden et al. found measurable improvements in fine lines with topical copper peptide formulations. The hydration and pigmentation claims she makes are consistent with the literature, though effect sizes in cosmetic studies tend to be modest.

On the injectable side, she is correct that there are no published human clinical trials. The research base is primarily in vitro and animal models. Pickart's foundational work (1973, Nature) identified GHK as a plasma tripeptide with wound-healing properties, but that's a long way from a clinical protocol. The protein aggregation concern she raises is biologically plausible, though it hasn't been formally studied for GHK-Cu specifically.

What did they get wrong (or right)?

She got the regulatory framing mostly right but slightly overstated it. Saying injectable GHK-Cu is "not legal" is accurate in the sense that it lacks FDA approval as a drug product. But compounded peptides exist in a gray zone, not a hard prohibition. FDA has taken action against certain compounded peptides, and GHK-Cu is not on the FDA's approved drug list, but the legal situation is more complex than a flat "illegal" label. To her credit, she correctly identified the real risks: impurities, dosing errors, and unknown systemic effects.

Her topical claims are reasonable. Calling it "biologically very interesting" rather than a cure is the right register. The claim that it "can help" with hydration, fine lines, and pigment is appropriately hedged and supported by existing data. She also correctly noted it doesn't replace other skincare ingredients, which is a thing beauty influencers almost never say.

What should you actually know?

GHK-Cu is a tripeptide that occurs naturally in human plasma and declines with age. That part is real biology. The topical version has enough evidence behind it to be a reasonable addition to a skincare routine, particularly in formulations where it can penetrate the stratum corneum. Stability and formulation matter enormously here: copper peptides can oxidize and degrade, so the product you buy off TikTok Shop is not necessarily delivering what it claims.

For the injectable version, the risk calculus is genuinely unfavorable right now. There is no clinical dosing data in humans, no long-term safety profile, and real concerns about what compounded peptide products actually contain. A 2022 FDA warning letter to several compounding pharmacies flagged sterility and potency failures in injectable peptide products broadly. That's not a hypothetical risk.

• Topical GHK-Cu has peer-reviewed support for collagen stimulation and wound healing (Pickart and Margolina, 2018)
• Injectable GHK-Cu has no published human clinical trials
• Compounded injectable peptides have documented contamination and dosing issues per FDA enforcement actions
• Protein aggregation at high peptide doses is a legitimate pharmacological concern, not just fearmongering
• Formulation quality determines whether topical GHK-Cu actually does anything in a consumer product